Media Release: SURVIVEiT® Launches Its Cancer Navigation Tool: Lung Edition
First-Ever Interactive Tool Helps Lung Cancer Patients Navigate Their Cancer Journey
(Denver, CO, NOV 17, 2020) – SURVIVEiT®, an organization that envisions a world free from the fear of cancer, has launched its Cancer Navigation Tool: Lung Edition, a free, interactive, five-step personal cancer guide developed by survivors and oncology professionals for lung cancer patients. The Cancer Navigation Tool reimagines informed decision-making for patients and delivers on a philosophy that each individual should be equipped to define and navigate their cancer journey from the moment of diagnosis.
Now live on the SURVIVEiT website, this one-of-a-kind comprehensive Tool outlines the five steps to navigate the cancer journey:
- TESTiT - getting a thorough diagnosis via comprehensive molecular profiling
- VERIFYiT - gaining qualified second opinions and review of molecular profiling
- MATCHiT - defining your personal goals for treatment and quality of life
- SUPPORTiT - managing side effects and complementary therapies through treatment
- LIVEiT - survivor-vetted resource library for many aspects of managing the disease
The Tool is intended to address key issues in the oncology field such as patient understanding and recall issues, shared decision-making, and geographic barriers to care. By increasing access to molecular testing, expert remote second opinions, clinical trials, and supportive care, this navigation tool is poised to improve patient outcomes. SURVIVEiT also incorporated solutions to access optimum care with consideration to COVID-19.
“Based on 8 years of one-on-one coaching and collaboration among survivors, this Tool is the first comprehensive and actionable guide to navigate the entire cancer journey,” stated Joy Brewster Rusthoven, Executive Director at SURVIVEiT. “We designed it knowing that patients and caregivers are typically overwhelmed and feeling out of control after receiving a cancer diagnosis. We simplify and personalize the information presented and provide to-do lists so they can take action efficiently and intentionally.”
SURVIVEiT will expand and launch its Tool for 25+ cancer types in 2021. It was important to launch the lung edition first as lung cancer is the deadliest cancer for both males and females – accounting for 22% of all cancer deaths. Additionally, lung cancer has the most advancements in diagnostics and precision medicine therapeutics of all cancer types. Considering the fact that four in five adults use the internet to search for health information but many are not finding what they are looking for, the time is now for SURVIVEiT’s Cancer Navigation Tool.
"SURVIVEiT’s Tool is the perfect combination of what you need to know and how to plan,” commented Jeff Lombardo, PharmD and BCOP, Research Assistant Professor, University of Buffalo Center for Integrated Global Biomedical Sciences. “Cancer has enough unknowns. It’s time to navigate the information we have and control what we can.”
About SURVIVEiT
SURVIVEiT is a registered 501(c)(3) national cancer patient advocate. Our vision is a world free from the fear of cancer. Our mission is to empower you to define your journey and face cancer on your own terms.
Contact: [email protected]
Additional Information and Resources:
- SURVIVEiT’s Cancer Navigation Tool
- Tool Overview Video
- More information on SURVIVEiT® and how to make a donation
###